Scott Carter
About Scott Carter
Scott Carter is the Associate General Counsel and Head of Business Development Legal at BeiGene in the United States, specializing in biotechnology and pharmaceutical licenses.
Company
Scott Carter currently works at BeiGene in the United States. He holds the position of Associate General Counsel and Head of Business Development Legal. His role involves overseeing legal matters related to business development in the biotechnology and pharmaceutical sectors.
Title
Scott Carter is Associate General Counsel, Head of Business Development Legal at BeiGene. His responsibilities include managing legal aspects of business development, particularly focusing on biotechnology and pharmaceutical licenses, collaboration agreements, and material transfer agreements.
Previous Positions
Before his current role, Scott Carter was Assistant General Counsel, Business Development at BeiGene from 2019 to 2024 in Emeryville, CA. He served as Of Counsel at Morrison & Foerster LLP from 2017 to 2019, and as a Life Sciences Licensing Attorney at Wilson Sonsini Goodrich & Rosati from 2012 to 2017 in Palo Alto, CA. Earlier roles include serving as Life Science Licensing Attorney at Latham & Watkins from 2010 to 2012, a Biotech/Pharma Attorney at Knobbe Martens Olson & Bear LLP for five months in 2009-2010, and a Life Science Licensing Attorney at Latham & Watkins from 2006 to 2009. He began his career as Assistant Director, Technology Transfer at California Institute of Technology from 2000 to 2006.
Education and Expertise
Scott Carter holds a J.D. from the University of California, Los Angeles - School of Law, obtained between 2003 and 2006. He has a Ph.D. in Chemistry, Biochemistry from Caltech, earned from 1992 to 1998, and an A.B. in Biochemistry from Amherst College, awarded from 1988 to 1992. He specializes in biotechnology and pharmaceutical licenses, collaboration agreements, and material transfer agreements.
Industry Contributions
During his tenure at Caltech, Scott Carter managed the Life Science patent portfolio and negotiated and drafted various agreements including license, research, and material transfer agreements. He also advised entrepreneurs at Caltech on starting new ventures such as GeneOhm Sciences, Proteolix, and Allozyne. His work included prosecuting biotech patent applications and providing technical consultation on patent litigation.